Ilise Lombardo

3.3k total citations · 2 hit papers
41 papers, 2.5k citations indexed

About

Ilise Lombardo is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Ilise Lombardo has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Pharmacology. Recurrent topics in Ilise Lombardo's work include Schizophrenia research and treatment (14 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Bipolar Disorder and Treatment (8 papers). Ilise Lombardo is often cited by papers focused on Schizophrenia research and treatment (14 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Bipolar Disorder and Treatment (8 papers). Ilise Lombardo collaborates with scholars based in United States, Sweden and Denmark. Ilise Lombardo's co-authors include Lawrence Friedhoff, Geetha Ramaswamy, Stephen C. Piscitelli, Marc Laruelle, Dah‐Ren Hwang, Anissa Abi‐Dargham, Yiyun Huang, Ronald Van Heertum, Osama Mawlawi and Diana Martínez and has published in prestigious journals such as Journal of Neuroscience, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Ilise Lombardo

41 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

2015 583 citations Ilise Lombardo, Geetha Ramaswamy et al. Alzheimer s & Dementia profile →
Prefrontal Dopamine D₁Receptors and Working Memory in Schizophrenia

2002 567 citations Anissa Abi‐Dargham, Osama Mawlawi et al. Journal of Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilise Lombardo United States	20	892	800	664	528	390	41	2.5k
Norbert Dahmen Germany	32	625 0.7×	571 0.7×	736 1.1×	829 1.6×	381 1.0×	107	3.2k
William T. Regenold United States	26	802 0.9×	482 0.6×	517 0.8×	445 0.8×	244 0.6×	54	2.3k
Sridhar Natesan United Kingdom	25	1.2k 1.3×	870 1.1×	739 1.1×	435 0.8×	309 0.8×	52	2.7k
Ying‐Jay Liou Taiwan	30	881 1.0×	690 0.9×	593 0.9×	471 0.9×	303 0.8×	122	2.6k
Göran C. Sedvall Sweden	26	862 1.0×	1.3k 1.6×	727 1.1×	625 1.2×	278 0.7×	47	2.9k
Thomas J. Raedler Germany	21	946 1.1×	667 0.8×	534 0.8×	543 1.0×	162 0.4×	46	2.5k
Peter Powchik United States	25	1.4k 1.6×	466 0.6×	445 0.7×	629 1.2×	247 0.6×	58	2.3k
Kunitoshi Kamijima Japan	30	775 0.9×	540 0.7×	525 0.8×	566 1.1×	222 0.6×	108	3.0k
Raben Rosenberg Denmark	31	974 1.1×	627 0.8×	341 0.5×	644 1.2×	359 0.9×	83	3.1k
Fernando Caravaggio Canada	26	1.0k 1.1×	549 0.7×	334 0.5×	628 1.2×	315 0.8×	98	2.3k

Countries citing papers authored by Ilise Lombardo

Since Specialization

Citations

This map shows the geographic impact of Ilise Lombardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilise Lombardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilise Lombardo more than expected).

Fields of papers citing papers by Ilise Lombardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilise Lombardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilise Lombardo. The network helps show where Ilise Lombardo may publish in the future.

Co-authorship network of co-authors of Ilise Lombardo

This figure shows the co-authorship network connecting the top 25 collaborators of Ilise Lombardo. A scholar is included among the top collaborators of Ilise Lombardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilise Lombardo. Ilise Lombardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molinuevo, José Luís, Shankar Ramaswamy, Ilise Lombardo, & Bote G. Bruinsma. (2017). [P1–058]: RESPONDER ANALYSIS OF THE COGNITIVE EFFECT OF COMBINATION THERAPY WITH DONEPEZIL AND INTEPIRDINE (RVT‐101) VERSUS DONEPEZIL MONOTHERAPY: RESULTS FROM A 48‐WEEK MULTINATIONAL PLACEBO‐CONTROLLED STUDY IN MILD TO MODERATE ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 13(7S_Part_5). 2 indexed citations

Lombardo, Ilise, et al.. (2017). Intepirdine (RVT-101), a 5-HT6 Receptor Antagonist, as an Adjunct to Donepezil in Mild-to-Moderate Alzheimer's Disease: Efficacy on Activities of Daily Living Domains. American Journal of Geriatric Psychiatry. 25(3). S120–S121. 4 indexed citations

Keefe, Richard S.E., Nancy Dgetluck, Maria S. Gawryl, et al.. (2015). Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. Neuropsychopharmacology. 40(13). 3053–3060. 120 indexed citations

Lombardo, Ilise, Geetha Ramaswamy, Stephen C. Piscitelli, & Lawrence Friedhoff. (2015). DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study. Alzheimer s & Dementia. 11(7S_Part_7). 583 indexed citations breakdown →

Vieta, Eduard, Elizabeth Pappadopulos, Francine S. Mandel, & Ilise Lombardo. (2011). Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study. The International Journal of Neuropsychopharmacology. 14(8). 1017–1027. 26 indexed citations

Correll, Christoph U., Benjamin G. Druss, Ilise Lombardo, et al.. (2010). Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients. Psychiatric Services. 61(9). 892–898. 87 indexed citations

Frankle, W. Gordon, Ilise Lombardo, Lawrence S. Kegeles, et al.. (2010). Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. Journal of Psychopharmacology. 25(6). 734–743. 6 indexed citations

Stahl, Stephen M., Ilise Lombardo, Antony Loebel, & Francine S. Mandel. (2009). Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies. Journal of Affective Disorders. 122(1-2). 39–45. 28 indexed citations

Morrato, Elaine H., Brian J. Cuffel, John W. Newcomer, et al.. (2009). Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection. Journal of Clinical Psychopharmacology. 29(1). 26–32. 28 indexed citations

10.

Warrington, Lewis, Ilise Lombardo, Antony Loebel, & Kathleen Ice. (2007). Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder. CNS Drugs. 21(10). 835–849. 19 indexed citations

11.

Preskorn, Sheldon, et al.. (2007). P.3.c.067 Effect of meal size and fat content on oral ziprasidone absorption. European Neuropsychopharmacology. 17. S463–S463. 1 indexed citations

12.

Frankle, W. Gordon, Ilise Lombardo, Lawrence S. Kegeles, et al.. (2006). Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635. Psychopharmacology. 189(2). 155–164. 47 indexed citations

13.

Warrington, Lewis, et al.. (2006). P.3.c.056 Efficacy of ziprasidone in the treatment of schizoaffective disorder:an analysis of 2 fixed-dose, placebo-controlled trials. European Neuropsychopharmacology. 16. S427–S427. 1 indexed citations

14.

Frankle, W. Gordon, Rajesh Narendran, Yiyun Huang, et al.. (2005). Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB. Biological Psychiatry. 57(12). 1510–1516. 43 indexed citations

15.

Frankle, W. Gordon, Ilise Lombardo, Antonia S. New, et al.. (2005). Brain Serotonin Transporter Distribution in Subjects With Impulsive Aggressivity: A Positron Emission Study With [¹¹C]McN 5652. American Journal of Psychiatry. 162(5). 915–923. 182 indexed citations

16.

Kent, Justine, Jeremy D. Coplan, Ilise Lombardo, et al.. (2002). Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [ 11 C]McN 5652. Psychopharmacology. 164(4). 341–348. 52 indexed citations

17.

Abi‐Dargham, Anissa, Osama Mawlawi, Ilise Lombardo, et al.. (2002). Prefrontal Dopamine D₁Receptors and Working Memory in Schizophrenia. Journal of Neuroscience. 22(9). 3708–3719. 567 indexed citations breakdown →

18.

Abi‐Dargham, Anissa, Norman R. Simpson, Lawrence S. Kegeles, et al.. (1999). PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. Synapse. 32(2). 93–109. 103 indexed citations

19.

Aller, Stephen G., et al.. (1999). Cloning, characterization, and functional expression of a CNP receptor regulating CFTR in the shark rectal gland. American Journal of Physiology-Cell Physiology. 276(2). C442–C449. 47 indexed citations

20.

Boeri, D, et al.. (1992). Comparison of the Effects of Carvedilol and Nifedipine in Patients with Essential Hypertension and Non-Insulin-Dependent Diabetes Mellitus. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S86–S89. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact